Glycogen storage disease type II (NORD)

97,508views

Glycogen storage disease type II (NORD)

D115

D115

Systemic lupus erythematosus
Turner syndrome
Klinefelter syndrome
Fragile X syndrome
Prader-Willi syndrome
Angelman syndrome
Endocrine system anatomy and physiology
Restrictive lung diseases
Down syndrome (Trisomy 21)
Pyloric stenosis
Innate immune system
Antibody classes
HIV (AIDS)
Myasthenia gravis
Meningitis
Multiple sclerosis
Guillain-Barre syndrome
Delirium
Dementia with Lewy bodies
Alzheimer disease
Seizures and epilepsy
Normal pressure hydrocephalus
Huntington disease
Parkinson disease
Concussion and traumatic brain injury
Lambert-Eaton myasthenic syndrome
Major depressive disorder
Generalized anxiety disorder
Schizophrenia
Spina bifida
Phenylketonuria (NORD)
Tay-Sachs disease (NORD)
Cerebral palsy
Hyperparathyroidism
Hypoparathyroidism
Diabetes insipidus
Graves disease
Diabetes mellitus
Cushing syndrome
Primary adrenal insufficiency
Breast cancer
Benign prostatic hyperplasia
Ovarian cyst
Pneumonia
Chronic bronchitis
Asthma
Emphysema
Pulmonary embolism
Pneumothorax
Pleural effusion
Bronchiectasis
Acute respiratory distress syndrome
Mycobacterium tuberculosis (Tuberculosis)
Cor pulmonale
Bacterial epiglottitis
Laryngomalacia
Respiratory syncytial virus
Cystic fibrosis
Sudden infant death syndrome
Disseminated intravascular coagulation
Sickle cell disease (NORD)
Chronic leukemia
Acute leukemia
Myocardial infarction
Deep vein thrombosis
Hypoplastic left heart syndrome
Angina pectoris
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Iron deficiency anemia
Aplastic anemia
Autoimmune hemolytic anemia
Polycythemia vera (NORD)
Immune thrombocytopenia
Epstein-Barr virus (Infectious mononucleosis)
Non-Hodgkin lymphoma
Hodgkin lymphoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Beta-thalassemia
Alpha-thalassemia
Raynaud phenomenon
Arterial disease
Peripheral artery disease
Coronary artery disease: Pathology review
Pericarditis and pericardial effusion
Rheumatic heart disease
Heart failure
Patent ductus arteriosus
Ventricular septal defect
Pulmonary valve disease
Kawasaki disease
Tetralogy of Fallot
Urinary tract infections: Clinical
Kidney stones
Chronic kidney disease
Nephrotic syndromes: Pathology review
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Neurogenic bladder
Bladder exstrophy
Hypospadias and epispadias
Polycystic kidney disease
Hemolytic-uremic syndrome
Nephroblastoma (Wilms tumor)
Vesicoureteral reflux
Renal failure: Pathology review
Gastrointestinal bleeding: Pathology review
Gastroesophageal reflux disease (GERD)
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Zollinger-Ellison syndrome
Wilson disease
Malabsorption syndromes: Pathology review
Ulcerative colitis
Crohn disease
Irritable bowel syndrome
Diverticulosis and diverticulitis
Appendicitis
Portal hypertension
Intussusception
Celiac disease
Gastric cancer
Acute pancreatitis
Chronic pancreatitis
Chronic cholecystitis
Acute cholecystitis
Gallstones
Jaundice
Viral hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Hepatitis C virus
Cirrhosis
Biliary atresia
Hirschsprung disease
Paget disease of bone
Osteoporosis
Osteoarthritis
Atopic dermatitis
Varicella zoster virus
Osteomalacia and rickets
Bone tumors
Rheumatoid arthritis
Ankylosing spondylitis
Gout
Fibromyalgia
Hypothyroidism
Hypomagnesemia
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Myalgias and myositis: Pathology review
Polymyositis
Dermatomyositis
Lordosis, kyphosis, and scoliosis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Muscular dystrophy
Scleroderma
Psoriasis
Lichen planus
Pemphigus vulgaris
Acne vulgaris
Erythema multiforme
Stevens-Johnson syndrome
Lyme Disease
Herpes simplex virus
Skin cancer
Human herpesvirus 8 (Kaposi sarcoma)
Rubella virus
Measles virus
Burns
Shock
Cri du chat syndrome
Prostate cancer
Post-traumatic stress disorder
Wiskott-Aldrich syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Persistent truncus arteriosus
Membranoproliferative glomerulonephritis
Poststreptococcal glomerulonephritis
Menstrual cycle

Transcript

Watch video only

Pompe disease, also called glycogen storage disease type II, is a genetically inherited condition caused by insufficient functioning of an enzyme called lysosomal acid alpha-1,4-glucosidase, or just acid alpha-glucosidase, and it’s caused by a mutation of the GAA gene. It’s named after the Dutch pathologist, Dr. J.C. Pompe, who first described it in 1932.

Glucose is used for energy by most cells of the body, and it’s stored inside the cells as a compact, branch-shaped molecule called glycogen. When a cell needs energy, it uses enzymes to remove glucose molecules from the branches. One of the organelles within the cell is the lysosome, which functions a bit like a tiny recycling plant. The lysosome contains enzymes that break down cellular substances so that they can be recycled. Now for some reason, and it’s not really understood why, but small amounts of glycogen end up in the lysosomes, where it’s broken down by an enzyme called acid alpha-glucosidase, to release glucose from the glycogen chain.

In Pompe disease, a mutation of the GAA gene prevents the production of enough functional acid alpha-glucosidase, and as a result, lysosomes can’t break down glycogen. This leads to a buildup of glycogen within the cytoplasm and lysosomes, and that leads to cellular damage and destruction.

Now, normally, glycogen is found in the largest amounts in the cytoplasm of liver cells and all three types of muscle cell. In individuals with Pompe, glycogen mostly accumulates in the lysosomes of those cells. Skeletal muscles include various muscles of the body as well as the diaphragm which is the primary breathing muscle. Cardiac muscle makes up the majority of the heart, and smooth muscle is found in the walls of blood vessels and many other organs.

Pompe disease is an autosomal recessive condition - so in other words, both parents must be carriers. The severity of the condition depends on how much functional acid alpha-glucosidase is produced. If little to no enzyme exists, the infantile-form of the condition typically occurs. Within the first few months of life, muscular damage to the heart develops, causing hypertrophic cardiomyopathy or an enlarged heart and eventual heart failure. Skeletal muscle weakness causes severely decreased muscle tone of the entire body. Weakness of the diaphragm and other breathing muscles lead to respiratory failure as well. Other findings include an enlarged liver which is thought to be largely due to heart failure, and a large tongue, which is primarily made of muscle.